Education
About Us
Working with TipRanks
Follow Us
Silo Pharma (SILO)
NASDAQ:SILO
SILO Stock Chart & Stats
$0.38
$0.84(77.06%)
At close: 4:00 PM EST
$0.38
$0.84(77.06%)
Day’s Range― - ―
52-Week Range$0.36 - $3.37
Previous CloseN/A
Volume152.45M
Average Volume (3M)2.39M
Market Cap
$5.05M
Enterprise ValueN/A
Total Cash (Recent Filing)$5.94M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.50
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding13,318,273
10 Day Avg. Volume1,147,427
30 Day Avg. Volume2,386,494
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)0.65
Price to Sales (P/S)45.43
P/FCF Ratio-0.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Silo Pharma News
SILO FAQ
What was Silo Pharma’s price range in the past 12 months?
Silo Pharma lowest stock price was $0.36 and its highest was $3.37 in the past 12 months.
What is Silo Pharma’s market cap?
Silo Pharma’s market cap is $5.05M.
When is Silo Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Silo Pharma’s earnings last quarter?
Currently, no data Available
Is Silo Pharma overvalued?
According to Wall Street analysts Silo Pharma’s price is currently Overvalued.
Does Silo Pharma pay dividends?
Silo Pharma does not currently pay dividends.
What is Silo Pharma’s EPS estimate?
Silo Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Silo Pharma have?
Silo Pharma has 13,318,273 shares outstanding.
What happened to Silo Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Silo Pharma?
Currently, no hedge funds are holding shares in SILO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Silo Pharma
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Technical Analysis
Matinas BioPharma
―
Nucana
―
Adial Pharmaceuticals
―
Aprea Therapeutics
―
Alzamend Neuro
―
Ownership Overview
1.63% Insiders
0.37% Mutual Funds
10.92% Other Institutional Investors
82.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---